Mirion Technologies : Investor Day Presentation

MIR

Investor Day 2024

2024 Investor Day Schedule

SECTION

THEME

SPEAKER

2:00 p.m. ET

Welcome & Agenda

Eric Linn, IR

Company Overview

2:05 p.m. ET

Harnessing Power for Growth

Thomas Logan, CEO

& Strategy

Nuclear & Safety

Loic Eloy, President

2:45 p.m. ET

Enabling the Nuclear Renaissance

Nuclear & Safety

BREAK (10 minutes)

3:15 p.m. ET

Medical

Ecosystems for Growth

Luis Rivera,

EVP Medical

Financial Strategy

Clear Path to Significant

3:35 p.m. ET

Brian Schopfer, CFO

and Outlook

Value Creation

Thomas Logan, CEO

3:55 p.m. ET

Q&A

Brian Schopfer, CFO

CONCLUDE - 4:30 p.m. ET

3

2024 Mirion

Investor Day

Leadership Focused on Execution

Thomas Logan

Brian Schopfer

Loic Eloy

Luis Rivera

Founding Chief Executive

Chief Financial Officer

President, Nuclear & Safety

EVP, Medical

Officer

4

2024 Mirion

Investor Day

Company Overview and Strategy

Thomas Logan, Founding Chief Executive Officer

Harnessing Power for Growth

5

2024 Mirion

Investor Day

Mirion

Harnessing Power for Growth

PURE

PLAY

MISSION

CRITICAL

ATTRACTIVE

END - MARKETS

Only pure play in ionizing radiation detection, measurement & analysis

Compulsory solutions for highly-regulated

industries with high cost of failure

Highly levered to the growing nuclear

and cancer care markets

6

2024 Mirion

Investor Day

Mirion Solutions

Applicable Across Wide Array of Verticals

Nuclear Power

NUCLEAR

Defense & Diversified

& SAFETY

Labs & Research

Radiation Therapy

MEDICAL

Nuclear Medicine

Dosimetry Services

36%

Revenue

by Segment

64%

Nuclear & Safety Medical

7

Pie chart data based on full year 2023

2024 Mirion

Investor Day

Mirion Overview

At-a-Glance

6% 3%

11%

Geographic

Revenue 48%

Contribution

32%

N. America

Europe

Other Asia

China

Other

$837M

Revenue

Trailing 12 Month

20-50

Year customer

relationships

27%

Recurring/

Replacement

Revenue

73%

Recurring /

Replacement

95%+

Presence in nuclear

reactors worldwide

>2,800 Employees

27%

Nuclear/

Medical

Revenue

Contribution

73%

Nuclear /

Other

Medical

100%

Presence in top 100

cancer centers in the U.S.

12

Countries with

Mirion Operations

8

Pie chart data based on full year 2023 revenue. Geography shown represents "ship-to" destinations

2024 Mirion

Investor Day

Mirion Culture Firmly Aligned with Strategic Priorities

Public Company Rigor Has Helped Accelerate Our Journey

MIRION STRATEGIC PRIORITIES

INNOVATION

CUSTOMER

FINANCIAL

OPERATIONAL

M&A

EXPERIENCE

COMPOUNDER

EXCELLENCE

MIRION VALUES

9

2024 Mirion

Investor Day

Positioned to Expand Global Leadership Position

in 17 of 19 #1 ProductCategories

Trusted Partner for the Most Demanding Applications

Committed to

Delivering

Shareholder

Value

400+ Engineers & Physicists

Critical Provider

Supporting Space

Exploration &

Big Science

Applications

Strong Network

Effect Driving

Share Gains and

Revenue Growth

10

2024 Mirion

Investor Day

Disclaimer

Mirion Technologies Inc. published this content on December 03, 2024, and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on December 03, 2024 at 18:54:03.313.